DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

GlaxoSmithKline (NYSE: GSK)

company name or ticker
Company Photos
(Click to zoom)

Could GlaxoSmithKline Be A Better Investment Than Gilead?

Why Sarepta Therapeutics Inc. Stock Soared By 17% in 2014

Sarepta Therapeutics stock has been whipsawed over the past year. Find out what's been the cause of its volatility and whether or not the stock can head higher.

Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14)

Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

Is It Time to Buy GlaxoSmithKline plc Stock?

GlaxoSmithKline's stock has had a rough year due to falling revenues. Can the stock rebound?

Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog

Terrific Stocks On Sale: Part 1

COPD Occurs Most Often in These 5 States

COPD affects more than 6% of the U.S. population and costs $50 billion in direct and indirect costs annually, but these five states have the highest occurrence rate in the country.

Vectura Group Following A Familiar Path

Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies